Skip to main content
Contact Us
Investors & Media
Stock Information
Press Releases
Events
SEC Filings
Annual Report and Proxy
Analyst Coverage
Investor FAQ
Corporate Governance
Email Alerts
IR/Media Contacts
Menu
Mission
Science Behind Muscle
Heart Failure
Hypertrophic Cardiomyopathy
Neuromuscular Disease
Medicines & Research
Pipeline
Publications
Clinical Trials
Access Policy
Company
Our Story
Vision
Values
Leadership Teams
Responsibility
Patient Advocacy
Community Engagement
Grants and Giving Programs
Resilience in the Fight Against ALS
Careers
Culture
Open Opportunities
Diversity, Equity, Inclusion & Respect
Internship Program
Post-Doc Program
Company
/
Board of Directors
/
David Morgans, Jr., PH.D.
David Morgans, Jr., PH.D.
Former EVP, Pre-Clinical Research & Development, Cytokinetics; Former VP, Drug Discovery and Early Development, Pliant Therapeutics; Executive Vice President of Drug Discovery, Maze Therapeutics